CDC reported human infection with highly pathogenic avian influenza A(H5N1) virus in Texas
On Apr. 5, 2024, the U.S. Centers for Disease Control and Prevention (CDC) announced that a person in…
On Apr. 5, 2024, the U.S. Centers for Disease Control and Prevention (CDC) announced that a person in…
On Apr. 3, 2024, the U.S. Food and Drug Administration approved Basilea Pharmaceutica’s Zevtera (ceftobiprole medocaril sodium for…
On Apr. 1, 2024, Otsuka Pharmaceutica and Click Therapeutics announced that the U.S. Food and Drug Administration (FDA)…
On Mar. 29, 2024, the California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated…
On Mar. 27, 2024, researchers from Trinity College Dublin announced they had recovered remarkably preserved microbiomes from two…
On Mar. 22, 2024, the U.S. Food and Drug Administration (FDA) issued the an emergency use authorization for…
On Mar. 21, 2024, Harvard Medical School physician-scientists at Massachusetts General Hospital announced they had successfully transplanted a…
On Mar. 21, 2024, Eledon Pharmaceuticals announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a…
On Mar. 21, 2024, the U.S. Food and Drug Administration (FDA) approved Italfarmaco’s Duvyzat (givinostat) oral medication for…
On Mar. 20, 2024, a National Institutes of Health-supported study reported that SARS-CoV-2, the virus that causes COVID-19,…
On Mar. 19, 2024, the American Chemical Society announced it awarded The Priestley Medal to Carolyn R. Bertozzi…
On Mar. 19, 2024, researchers at Massachusetts Institute of Technology (MIT) and the University of Helsinki have now…
On Mar. 18, 2024, the U.S. Environmental Protection Agency (EPA) announced a final rule to prohibit ongoing uses…
On Mar. 18, 2024, the U.S. Food and Drug Administration (FDA) approved Orchard Therapeutics’ Lenmeldy (atidarsagene autotemcel), the…
On Mar. 14, 2024, Microsoft and the Fred Hutch announced a collaboration to end cancer faster, applying machine…
On Mar. 14, 2024, the U.S. Food and Drug Administration (FDA) approved Madrigal Pharmaceuticals’ Rezdiffra (resmetirom) for the…
On Mar. 13, 2024, researchers at the National Institutes of Health (NIH) announced they had discovered that symptoms…
On Mar. 13, 2024, the Fred Hutchinson Cancer Center announced that a blood test intended for screening for…
On Mar. 13, 2024, the National Science Board (NSB) published The State of U.S. Science and Engineering 2024,…
On Mar. 11, 2024, the Institute for Health Metrics and Evaluation (IHME) released all-cause mortality, life expectancy, and…
On Mar. 8, 2024, the U.S. Food and Drug Administration approved a new indication for use of Novo…
On Mar. 4, 2024, Hugel America announced it received U.S. Food and Drug Administration (FDA) approval on its…
On Mar. 1, 2024, researchers at the National Institutes of Health (NIH) announced they had identified antibodies targeting…
On Feb. 28, 2024, the CDC Advisory Committee on Immunization Practices’ (ACIP) announced a recommendation for adults ages…
On Feb. 23, 2024, the California Institute for Regenerative Medicine (CIRM), the world’s largest institution dedicated to regenerative…
On Feb. 22, 2024, the University of California, San Francisco (UC, San Francisco) launched the world’s first tissue…
On Feb. 21, 2024, the Fred Hutchinson Cancer Center announced it was at the helm of a new…
On Feb. 21, 2024, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it had approved $98,592,155…
On Feb. 16. 2024, Roche announced today that the U.S. Food and Drug Administration (FDA) has approved Xolair…
On Feb. 16, 2024, Regeneron and Sanofi announced that the Ministry of Health, Labor and Welfare (MHLW) in…